Michael Schaeffer
Director/Board Member chez VIVORYON THERAPEUTICS N.V.
Fortune : - $ au 29/02/2024
Profil
Founder of Crelux GmbH and SiREEN AG, Michael Schaeffer is Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
Dr. Schaeffer previously held the position of Chief Executive Officer & Managing Director at SiREEN AG and Chief Executive Officer & Managing Director at Crelux GmbH.
Dr. Schaeffer received a doctorate from Ludwig-Maximilians-Universität München.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
04/03/2024 | 0 ( -.--% ) | - $ | 29/02/2024 |
Postes actifs de Michael Schaeffer
Sociétés | Poste | Début |
---|---|---|
VIVORYON THERAPEUTICS N.V. | Director/Board Member | - |
Anciens postes connus de Michael Schaeffer
Sociétés | Poste | Fin |
---|---|---|
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Chief Executive Officer | 01/03/2016 |
SiREEN AG | Chief Executive Officer | 01/01/2004 |
Formation de Michael Schaeffer
Ludwig-Maximilians-Universität München | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VIVORYON THERAPEUTICS N.V. | Health Technology |
Entreprise privées | 2 |
---|---|
SiREEN AG | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Health Technology |